Chest Pain News and Research

RSS

Most women 55 years and younger who have heart attacks don't recognize warning signs

Women younger than 55 years represent less than 5 percent of all hospitalized heart disease patients, but because so many heart attacks occur in the United State each year, even this small percentage affects a large number of people.

11 May 2007

Health care professionals should inform sensitive patients about the risks of exposure to air pollutants

If you have some form of lung or cardiovascular disease, has your doctor told you how to check today's "AQI", and what to do if it's over 100?

11 May 2007

Theophylline offers relief for unexplained chest pain

The discomfort caused by esophageal (non-cardiac) chest pain is often severe, driving many patients to emergency rooms and physicians' offices despite the fact that the ailment has no definable pathology.

10 May 2007

Ischemic-targeted approach to angioplasty among asymptomatic survivors of heart attack

When compared with intensive drug therapy, percutaneous coronary intervention (PCI, angioplasty) was more beneficial in reducing the long-term risk of major cardiac events among heart attack survivors with "silent ischemia", according to a study in the May 9 issue of Journal of the American Medical Association.

9 May 2007

Efforts to standardize heart care are working

People who suffer a heart attack or severe chest pain today are much less likely to die, or to experience long-lasting effects, than their counterparts even a few years ago, according to a new international study in the May 3 issue of the Journal of the American Medical Association.

2 May 2007

Sticking with guidelines for acute coronary syndromes benefits even very elderly patients

Some say age 90 is the new age 70. If so, there's never been a better time for elderly patients to discuss with family and physicians just how aggressive medical care should be in case of a threatened or definite heart attack.

24 Apr 2007

Migraine associated with increased risk of subsequent major cardiovascular disease in men

Men with migraine headaches may be at an increased risk for major cardiovascular disease and especially heart attacks, according to a report in the April 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

24 Apr 2007

Are higher doses and higher costs for cholesterol drugs worth the extra money?

When it comes to cholesterol-lowering drugs, more is better. At least, that's what heart doctors and heart patients have been hearing in recent years.

24 Apr 2007

Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults

A new review suggests that asthma treatment based on tests of fluid coughed up from the lungs could reduce the frequency and severity of flare-ups in adult asthma patients.

19 Apr 2007

New, updated guidelines for esophageal reflux testing

Developed and approved by the American College of Gastroenterology, these guidelines summarize advances in gastroesophageal reflux disease (GERD) diagnostic testing and how they have modified the clinical management of esophageal disorders.

14 Apr 2007

Advances in clinical cardiology

Three studies being presented at the American College of Cardiology's Innovation in Intervention: i2 Summit 2007 in New Orleans, La., highlight the breadth of research propelling advances in clinical cardiology.

3 Apr 2007

Trial of percutaneous coronary intervention added to optimal medical therapy in patients with stable coronary heart disease

Percutaneous coronary interventions (PCI) involve opening partially blocked arteries to improve blood flow to the heart. These procedures are performed more than 1 million times a year.

3 Apr 2007

$Drug that mimics HDL does not reduce risk of death for heart attack patients with refractory shock$

Drug that mimics HDL does not reduce risk of death for heart attack patients with refractory shock

Patients with acute coronary syndromes (ACS), such as heart attack and recent-onset chest pain, remain at considerable risk of experiencing further serious cardiovascular problems despite improvements in care.

2 Apr 2007

Coronary procedure adds no benefit over 'optimal medical therapy' alone

Percutaneous coronary intervention plus optimal medical therapy does not improve outcomes in patients with coronary artery disease, compared with optimal medical therapy alone, according to study results presented at the 56th Annual Scientific Session of the American College of Cardiology in New Orleans, and published online in the New England Journal of Medicine.

1 Apr 2007

Novel anti-oxidant and anti-inflammatory agent reduces coronary events

Heart attacks are caused by a build-up and instability of plaque in the coronary arteries, which is often a result of chronic inflammation of the blood vessel walls.

31 Mar 2007

FDA announces marketing halt for GI drug, Zelnorm

The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.

30 Mar 2007

Angioplasty doesn't outweigh medicine in study

In what some leading cardiologists are calling a "blockbuster" study, new research could alter the approach to treating patients who have cardiovascular disease but may not be at immediate risk of heart attack or stroke.

30 Mar 2007

Medications plus lifestyle changes work as well as angioplasty to reduce deaths in stable heart-disease patients

Coronary revascularization with stenting or balloon angioplasty combined with optimal medical therapy is no more effective in preventing a heart attack, other major cardiovascular events or death in patients with stable heart disease, than optimal medical therapy alone, results of a new study conducted in 50 hospitals in the U.S. and Canada has shown.

27 Mar 2007

Lipitor given the green light for more heart risk patients

The Food and Drug Administration (FDA) in the U.S. has given approval for the best seller drug Lipitor to be used in five new categories.

8 Mar 2007

Erectile dysfunction drugs may be better than nitroglycerin in protecting the heart after a severe heart attack

During a heart attack, the heart is deprived of oxygen, which can result in significant damage to heart muscle and tissue. After the attack, most patients require treatment to reduce and repair the damage and improve their chances of survival.

5 Mar 2007

Chest Pain News and Research

Most women 55 years and younger who have heart attacks don't recognize warning signs

Health care professionals should inform sensitive patients about the risks of exposure to air pollutants

Theophylline offers relief for unexplained chest pain

Ischemic-targeted approach to angioplasty among asymptomatic survivors of heart attack

Efforts to standardize heart care are working

Sticking with guidelines for acute coronary syndromes benefits even very elderly patients

Migraine associated with increased risk of subsequent major cardiovascular disease in men

Are higher doses and higher costs for cholesterol drugs worth the extra money?

Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults

New, updated guidelines for esophageal reflux testing

Advances in clinical cardiology

Trial of percutaneous coronary intervention added to optimal medical therapy in patients with stable coronary heart disease

Drug that mimics HDL does not reduce risk of death for heart attack patients with refractory shock

Coronary procedure adds no benefit over 'optimal medical therapy' alone

Novel anti-oxidant and anti-inflammatory agent reduces coronary events

FDA announces marketing halt for GI drug, Zelnorm

Angioplasty doesn't outweigh medicine in study

Medications plus lifestyle changes work as well as angioplasty to reduce deaths in stable heart-disease patients

Lipitor given the green light for more heart risk patients

Erectile dysfunction drugs may be better than nitroglycerin in protecting the heart after a severe heart attack

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News